Semaglutide is an effective tool when used correctly by people who actually qualify
Patients with certain FTO or MC4R profiles may respond better to evening injections that align with their natural appetite peaks, while strong GLP1R responders often succeed with morning or evening timing equally
Start from the weekly milligram dose, then convert it to milliliters and U-100 syringe units using the vial concentration
With files from Jennifer La Grassa, The Canadian Press and Reuters
Wegovy injections are FDA approved for adults and children 12 years and older with a body mass index of 30 or more, or patients with additional conditions, such as high cholesterol, hypertension, sleep apnea, type 2 diabetes, heart disease, or other chronic metabolic illnesses, who have body mass index of 27 or more